Jennison Associates’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-31,044
| Closed | -$6.25M | – | 674 |
|
|
2019
Q1 | $6.25M | Sell |
31,044
-23,028
| -43% | -$4.63M | 0.01% | 456 |
|
|
2018
Q4 | $10.1M | Sell |
54,072
-7,224
| -12% | -$1.35M | 0.01% | 433 |
|
|
2018
Q3 | $14.7M | Buy |
61,296
+278
| +0.5% | +$66.5K | 0.01% | 434 |
|
|
2018
Q2 | $16.1M | Buy |
61,018
+814
| +1% | +$215K | 0.02% | 427 |
|
|
2018
Q1 | $14.9M | Buy |
60,204
+4,466
| +8% | +$1.11M | 0.01% | 426 |
|
|
2017
Q4 | $7.54M | Buy |
55,738
+335
| +0.6% | +$45.3K | 0.01% | 477 |
|
|
2017
Q3 | $6.57M | Sell |
55,403
-464
| -0.8% | -$55K | 0.01% | 494 |
|
|
2017
Q2 | $5.36M | Sell |
55,867
-2,314
| -4% | -$222K | 0.01% | 499 |
|
|
2017
Q1 | $10.8M | Buy |
58,181
+352
| +0.6% | +$65.6K | 0.01% | 480 |
|
|
2016
Q4 | $6.29M | Buy |
57,829
+831
| +1% | +$90.4K | 0.01% | 497 |
|
|
2016
Q3 | $9.13M | Buy |
56,998
+1,475
| +3% | +$236K | 0.01% | 476 |
|
|
2016
Q2 | $6.69M | Buy |
+55,523
| New | +$6.69M | 0.01% | 479 |
|